Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002533 · ClinicalTrials.gov registry record · Phase 2
Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer
A Phase 2 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00002533: Completed Phase 2 study, sponsored by University of Miami.
NCT00002533 is a Phase 2 study that has completed, run by University of Miami. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002533, a Phase 2 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Giving fluconazole may be effective in preventing or controlling mucositis caused by radiation therapy to the head and neck. PURPOSE: Randomized phase II/III trial to study the effectiveness of fluconazole in preventing mucositis in patients undergoing radiation therapy for head and neck cancer.
Interventions
- RADIATION radiation therapy
- DRUG fluconazole
Trial Details
| Field | Value |
|---|---|
| Start Date | 1993-02 |
| Est. Completion | 2006-08 |
| Phase | Phase 2 |
What the finished NCT00002533 record still lists
NCT00002533 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which radiation therapy is the first listed.
NCT00002533 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002533 about?
NCT00002533 is a clinical study titled "Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer". RATIONALE: Giving fluconazole may be effective in preventing or controlling mucositis caused by radiation therapy to the head and neck. PURPOSE: Randomized phase II/III trial to study the effectiveness of fluconazole in preventing mucositis in patients undergoing radiation therapy for head and neck...
What is the current status of trial NCT00002533?
This trial is currently completed. It is a Phase 2 study. The study started on 1993-02. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00002533?
The interventions under investigation include: radiation therapy (RADIATION), fluconazole (DRUG).
Who is sponsoring clinical trial NCT00002533?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia